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Bordetella pertussis is an important human respiratory pathogen. Here, we describe a
loop-mediated isothermal amplification (LAMP) method for the rapid detection of B. per-
tussis in clinical samples based on a visual test. The LAMP assay detected the BP485
target sequence within 60 min with a detection limit of 1.3 pg/µl, a 10-fold increase in
sensitivity compared with conventional PCR. All 31 non-pertussis respiratory pathogens
tested were negative for LAMP detection, indicating the high specificity of the primers for
B. pertussis. To evaluate the application of the LAMP assay to clinical diagnosis, of 105
sputum and nasopharyngeal samples collected from the patients with suspected respira-
tory infections in China, a total of 12 B. pertussis isolates were identified from 33 positive
samples detected by LAMP-based surveillance targeting BP485. Strikingly, a 4.5 months
old baby and her mother were found to be infected with B. pertussis at the same time.
All isolates belonged to different B. pertussis multilocus sequence typing groups with dif-
ferent alleles of the virulence-related genes including four alleles of ptxA, six of prn, four
of tcfA, two of fim2, and three of fim3. The diversity of B. pertussis carrying toxin genes
in clinical strains indicates a rapid and continuing evolution of B. pertussis. This combined
with its high prevalence will make it difficult to control. In conclusion, we have developed a
visual detection LAMP assay, which could be a useful tool for rapid B. pertussis detection,
especially in situations where resources are poor and in point-of-care tests.
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INTRODUCTION
Bordetella pertussis, a Gram-negative bacterium first reported in
1906 (1), is an important human-specific respiratory pathogen
that causes whooping cough (pertussis) in humans. Although the
morbidity and mortality of B. pertussis have been dramatically
reduced since the introduction of Pw and Pa vaccines into the
routine immunization schedule of infants, pertussis is consid-
ered as the most prevalent vaccine-preventable disease (2). It was
revealed that neonates are now commonly infected by adolescents
and adults, before transmitting whooping cough further to infants
and other groups. This change in transmission pattern from “child
to child” to “adult to child” may be the major cause for the ris-
ing incidence of pertussis, especially in developed countries with
high vaccination coverage (3–7). In China, pertussis is a reportable
infectious disease, and although the number of reported cases has
been decreasing, pertussis remains endemic. A diagnosis is made
on the basis of clinical symptoms, not using diagnostic tests such
as culture, PCR, and serologic analysis. Therefore, the reported
low incidence may, in fact, be due to substantial underreporting
caused by misdiagnosis. However, timely and accurate diagnosis is
necessary for controlling the disease.
Various diagnostic tests have been established, such as cul-
ture (8), PCR (9, 10), real-time PCR (11, 12), and enzyme-linked
immunosorbent assay (13). Methods based on molecular biology
or immunology have become universal and are increasingly replac-
ing culture-based methods, as they are more rapid and sensi-
tive. However, all of the above methods are time-consuming and
require specialized equipment.
Loop-mediated isothermal amplification (LAMP) is a sim-
ple and cost-effective nucleic acid amplification method, which
can be applied to rapidly detect B. pertussis. A LAMP assay
can be completed within 1 h at a constant temperature using
simple instruments. Further advantages include its high sen-
sitivity and specificity. LAMP has previously been used to
detect B. pertussis (14–17). Previously described PCR and LAMP
assays have typically used IS481, which is present in more than
200 copies in the B. pertussis genome, as the target sequence
(18, 19). However, because B. holmesii and some B. bron-
chiseptica strains contain the same IS481 elements, these assays
lacked specificity (20, 21). In 2008, Probert et al. compared
the genomes of B. pertussis, B. bronchiseptica, and B. parap-
ertussis, and tested the BP283 and BP485 sequences for the
specific detection of B. pertussis using real-time PCR. They
reported an improvement in specificity over assays targeting only
IS481 (22). Our study is the first to use BP485 as the target
sequence in a LAMP assay. The purpose of the present study
was to develop a rapid and simple test for B. pertussis detec-
tion, based on LAMP technology, which requires only basic
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equipment and allows immediate interpretation of results by visual
inspection.
MATERIALS AND METHODS
BACTERIAL ISOLATES, IDENTIFICATION, AND MLST TYPING
Thirty-four bacterial strains were used for specificity analysis,
which are listed in Table 1. Three B. pertussis vaccine strains
were tested, including strain 18530, which originated from United
States, strain P3s10, which has been used to produce Pw vaccines
since the early 1960s, and strain CS, which has been used to pro-
duce Pa vaccines since 1995. Paired sputum and nasopharyngeal
swabs were collected from 105 hospitalized patients using rayon-
tipped swabs (Copan Diagnostics; Corona, CA, USA) between the
spring of 2010 and spring of 2014. The patients (age range, 14 days
to 35 years; median, 1.33 years; 52 females, 50 males) came from
rural areas of China and had been treated for coughs and pneu-
monia for more than 7 days. Ten pairs of sputum samples and
nasopharyngeal swabs from healthy people were also collected as
controls. One swab or sputum sample was immediately placed
in Regan-Lowe transport medium for culture and the other was
stored at−70°C in an empty sterile tube for bacterial nucleic acid
isolation.
Bordetella pertussis strains were cultured on Bordet–Gengou
agar supplemented with 15% defibrinated sheep blood for 4–
5 days at 37°C. Species identification was carried out using the
Phoenix Automated Microbiology System (BD Diagnostic Sys-
tems) and matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) mass spectrometry. Genomic DNA was
extracted from all samples using TIANamp Bacteria DNA Kit
(TIANGEN Co., Ltd., Beijing, China). The sequences of 16S ribo-
somal DNA (rDNA) and BP485 were validated by PCR-based
sequencing and showed 100% identity with those previously
reported.
Seven housekeeper genes including adk, fumC, glyA, tyrB, icd,
pepA, and pgm were detected by PCR. The allele number for each
gene was assigned on the basis of the information in the B. pertus-
sis MLST database1. Moreover, the strains were screened for the
presence of 5 virulence-related genes (prn, ptxA, tcfA, fim2, and
fim3) by PCR as previously reported (23).
PRIMER DESIGN FOR LAMP
The sequence of BP485 (Accession number: CP002695.1) was
downloaded from NCBI GenBank database and further analyzed
by Primer Explorer Version 42. Five primer sets were designed and
synthesized commercially (Sangon Biotech Co., Ltd., Shanghai,
China).
LAMP ASSAY
Loop-mediated isothermal amplification assays were carried out
using the Loopamp DNA Amplification kit (Eiken Chemical Co.,
Ltd., Tochigi, Japan). Briefly, the LAMP amplification system in a
final volume of 25µl contained 12.5µl reaction mixture, 1µl Bst
DNA polymerase, 2µl template for real-time turbidimeter, and
1http://pubmlst.org/bordetella
2http://primerexplorer.jp/elamp4.0.0/index.html
Table 1 | Bacterial strains used in this study.
No. Strain Source
1 B. pertussis ATCC18530 Our microorganism center
2 B. pertussis ATCC58003 Our microorganism center
3 B. pertussis ATCC53894 Our microorganism center
4 B. parapertussis CMCC 58302 Our microorganism center
5 B. parapertussis ATCC 15237 Our microorganism center
6 B. parapertussis ATCC BAA-587 Our microorganism center
7 B. parapertussis ATCC 53893 Our microorganism center
8 B. bronchiseptica ATCC BAA-588 Our microorganism center
9 B. bronchiseptica CMCC 58401 Our microorganism center
10 B. bronchiseptica ATCC 4617 Our microorganism center
11 B. holmesii ATCC 51541 Our microorganism center
12 B. avium ATCC 35086 Our microorganism center
13 B. hinzii ATCC 51730 Our microorganism center
14 B. petrii ATCC BAA-461 Our microorganism center
15 Corynebacterium diphtheriae
CMCC 38001
Our microorganism center
16 Haemophilus influenzae CMCC
58534
Our microorganism center
17 Betahaemolytic streptococcus
group A CMCC 32213
Our microorganism center
18 Streptococcus pneumonia CMCC
31001
Our microorganism center
19 Neisseria meningitides group
B CMCC 29022
Our microorganism center
20 Neisseria meningitides group
C CMCC 29026
Our microorganism center
21 Neisseria meningitides group
Y CMCC 29028
Our microorganism center
22 Neisseria meningitides group
A CMCC 29202
Our microorganism center
23 Mycobacterium tuberculosis 4368 Our microorganism center
24 Neisseria meningitides NM29019 Our microorganism center
25 Streptococcus pneumonia SP112-07 Our microorganism center
26 Legionella pneumophila LP9135 Our microorganism center
27 Haemophilus influenzae M5126 Our microorganism center
28 Klebsiella pneumonia 46117 Our microorganism center
29 Vibrio parahaemolyticus 5474 Our microorganism center
30 Salmonella enteritidis 50326-1 Our microorganism center
31 Salmonella paratyphi A 86423 Our microorganism center
32 Shigella flexneri 4536 Our microorganism center
33 Shigella sonnei 2531 Our microorganism center
34 EIEC 44825 Our microorganism center
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another 1µl calcein/Mn2+ solution for visual detection. Primers
were used at a concentration of 40 pmol for FIP and BIP, 20 pmol
for LB and LF, and 5 pmol for F3 and B3. The reaction mix was
overlaid with a sealing agent mainly comprised wax to prevent
cross contamination of samples by aerosol. During the amplifica-
tion, the protectant melted and became liquid without disturbing
the reaction, avoiding volatilization of amplified products after
reaction, and the protectant solidified as the temperature in the
tubes decreased (Patent: ZL201210371448.5 in China).
Amplification was monitored using two methods, real-time
changes in turbidity or visual detection of a color change.
Pyrophosphate ions are released during LAMP amplification that
with the addition of magnesium ions (Mg2+) in the reaction buffer
form a white magnesium pyrophosphate precipitate (24), which
can be monitored every 6 s at 650 nm using a real-time turbidime-
ter, and the data are transformed into turbidity curves. For visual
detection, 1µl of calcein/Mn2+ fluorescent detection reagent was
added to the reaction. LAMP amplification results in a green fluo-
rescent emission as a result of magnesium ions forming a complex
with calcein. The color change from orange to green when samples
are positive is visible to the naked eye (25). Each experiment was
performed at least three times.
PCR ASSAY
PCRs were setup using 12.5µl of PCR MasterMix reagents (Tian-
gen Biotech Co., Ltd., Beijing, China), 1µM BP-113F3 and BP-
113B3 primers, and 2µl of DNA template in a final volume of
25µl. PCR was performed using the following cycling conditions:
initial PCR activation, 95°C for 5 min; amplification, 40 cycles of
95°C for 30 s, 55°C for 30 s, and 72°C for 30 s; final extension,
72°C for 7 min. PCR products were visualized on a 1% agarose gel
stained with ethidium bromide. Images were documented with a
Gel Doc EQ imaging system (Bio-Rad).
RESULTS
OPTIMIZATION OF LAMP ASSAY
BP485 was targeted for detection of B. pertussis by a LAMP assay
for the first time. Five different primer sets were initially tested,
four of which resulted in successful amplification as shown in
Figure 1. The BP-113 primer set amplified the target sequence
within the shortest time and was therefore chosen as the optimal
primer set (Table 2).
Reaction temperatures from 60 to 67°C were compared for opti-
mal amplification. Amplification efficiency was highest at 64°C
(Figure 2) and was therefore used for later experiments.
SPECIFICITY OF LAMP ASSAY
To evaluate the specificity of LAMP detection for B. pertussis,
genomic DNA was extracted from B. pertussis ATCC18530, B.
pertussis ATCC58003, B. pertussis ATCC53894, and 31 other path-
ogenic respiratory bacteria and tested using real-time turbidity
or visual detection of color change as readouts. Both methods
of analysis positively identified the B. pertussis isolates. All other
strains, including the blank control, tested negative, indicating that
the LAMP assay was specific to B. pertussis (Figure 3).
FIGURE 1 | Five designed primer sets were tested by real-time
turbidimeter at 650 nm every 6 s. BP-113 group possess optimal
efficiency and was chosen to be final primers for LAMP assay.
Table 2 | Sequence of optimal primer set for LAMP assay.
Primer Length (bp) Sequence (5′–3′)
BP113-F3 19 GCGATCTCGATGCTTGACG
BP113-B3 20 CCTCATCTTCGTTCAGCGAA
BP113-FIP 44 AGAAACAGTGGCTCGATGGCGTTTTTTCACTA
TGGGCTGTCGTG
BP113-BIP 43 TTGATTGACAGGGCAATCCGGCTTTTGCGTGT
TTTCCCCAGAG
BP113-LF 17 GTGCTTGACGTGACCGC
BP113-LB 19 AATAGCGCAGTCCGGCGTA
bp, base pair.
FIGURE 2 | Different temperatures for LAMP reaction were tested
using real-time turbidimeter at 650 nm.
SENSITIVITY OF THE LAMP ASSAY VERSUS PCR FOR B. PERTUSSIS
To compare the detection limit of LAMP using either real-time
turbidity measurements or color change with traditional PCR,
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FIGURE 3 |The specificity detection of LAMP assay by real-time
turbidimeter (A) or addition calcein to the reaction tube (B). Amplification
was performed at 64°C for 60 min. 1, NC; 2, B. pertussis ATCC 18530; 3, B.
pertussis CMCC 58003; 4, B. pertussis ATCC 53894; 5, B. parapertussis
CMCC 58302; 6, B. parapertussis ATCC 15237; 7, B. parapertussis ATCC
BAA-587; 8, B. parapertussis ATCC 53893; 9, B. bronchiseptica ATCC
BAA-588; 10, B. bronchiseptica CMCC 58401; 11, B. bronchiseptica ATCC
4617; 12, B. holmesii ATCC 51541; 13, B. avium ATCC 35086; 14, B. hinzii
ATCC 51730; 15, B. petrii ATCC BAA-461; 16, Corynebacterium diphtheriae
CMCC 38001; 17, Haemophilus influenzae CMCC 58534; 18, Betahaemolytic
streptococcus group A CMCC 32213; 19, Streptococcus pneumonia CMCC
31001; 20, Neisseria meningitides group B CMCC 29022; 21, Neisseria
meningitides group C CMCC29026; 22, Neisseria meningitides group Y
CMCC 29028; 23, Neisseria meningitides group A CMCC 29202; 24,
Mycobacterium tuberculosis 4368; 25, Neisseria meningitides NM29019; 26,
Streptococcus pneumonia SP112-07; 27, Legionella pneumophila LP9135; 28,
Haemophilus influenzae M5216; 29, Klebsiella pneumonia 46117; 30, Vibrio
parahaemolyticus 5474; 31, Salmonella enteritidis 50326-1; 32, Salmonella
paratyphi A 86423; 33, Shigella flexneri 4536; 34, Shigella sonnei 2531; 35,
EIEC 44825.
10-fold serial dilutions of genomic DNA extracted from B. per-
tussis ATCC18530 (130 ng/µl to 1.3 fg/µl) were tested. The results
were shown in Figure 4. The detection limits of real-time turbidity
and visual detection were both 1.3 pg/µl, which was 10-fold more
sensitive than traditional PCR assay.
DISSEMINATION OF B. PERTUSSIS IN CLINICAL
A total of 105 clinical sputum samples and nasopharyngeal
swabs were collected for LAMP-based surveillance of BP485 from
patients with suspected respiratory infections in China during
2010–2014. Ten pairs of sputum samples and nasopharyngeal
swabs from healthy people were collected as controls. All clinical
samples were analyzed by LAMP and PCR simultaneously. As
shown in Table 3, of the 105 clinical samples, LAMP detected
33 positive samples while 23 were detected by PCR. Then, B. per-
tussis was successfully cultured from 12 samples, all of which had
been positively identified by LAMP. The healthy control samples
all tested negative in each of the assays.
The sequence analysis of the BP485 gene from the B. pertus-
sis isolates confirmed conservation with the nucleotide sequences
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FIGURE 4 | Comparative sensitivities of both LAMP assay (A,B) and traditional PCR (C). Lane M: DL2000 Marker; Tubes 1–9 and lanes 1–9: 10-fold serial
dilution pure genomic DNA extracted from B. pertussis (130 ng/µl to 0.0013 pg/µl); Tube 10 and lane 10: ddH2O as negative control.
of reported genes. Multilocus sequence typing (MLST) analysis
of B. pertussis showed that five of the seven housekeeping genes
belonged to a single genotype, similar to reported global geno-
types. However, the adk and tyrB housekeeping genes had two
different genotypes belonging to type 1 and type 3, respectively.
To further characterize the virulence-related genes of the 12
isolated strains, the alleles of ptxA, prn, tcfA, fim2, and fim3 were
analyzed. All isolates had virulence-related genes belonging to dif-
ferent genotypes with all four ptxA alleles, six prn alleles, four tcfA
alleles, two fim2 alleles (fim2-1 and fim2-2), and three fim3 alleles
(fim3-1, fim3-2, and fim3-4) present across the samples. Our data
show that B. pertussis is widespread in respiratory infections, and
the diverse genotypic features indicate on-going evolution.
DISCUSSION
Pertussis, also known as whooping cough, is an acute respiratory
infectious disease caused by B. pertussis, and can cause severe dis-
ease, particularly in infants. Although vaccines are widely used in
most countries, the morbidity of pertussis is rising, even in devel-
oped countries with high vaccination coverage. Remarkably, many
adolescents and adults become infected despite having been vac-
cinated as infants as a result of waning antibody titers, which can
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Table 3 | Evaluation of LAMP and PCR for detection of B. pertussis in 105 clinical samples.
Gene Type of samples No. of samples tested No. of positive
samples for assay
Culture PCR LAMP
BP485 Clinical nasopharyngeal swabs from patients 105 12 23 33
Nasopharyngeal swabs from healthy people 10 0 0 0
result in further transmission to children. Unfortunately, conven-
tional wisdom holds that pertussis is a pediatric disease, leading to
substantial under-diagnosis in adolescents and adults. Pertussis is
highly infectious, and therefore rapid and simple methods to aid
diagnosis would be advantageous in controlling disease spread.
Several diagnostic techniques have been established for detect-
ing B. pertussis, e.g., culture, serological assays, and, most com-
monly, PCR-based methods. These approaches are either time-
consuming or costly and frequently require skilled technicians and
precision instruments. They are therefore not suitable for situa-
tions where resources are limited and fast results are required such
as for point-of-care assessments. Since its introduction in 2000,
a nucleic amplification method known as LAMP (26) has been
widely used in various fields, including clinical diagnosis, food
safety, livestock breeding, and even determination of sex (27, 28).
A number of reports indicated that LAMP had a better sensitivity
and specificity for detecting pathogens than other commonly used
methods. Here, we described a LAMP method for detecting BP485
of B. pertussis by color change.
Although many target genes, such as IS481, have been used to
diagnose pertussis, we chose BP485, which, unlike IS481, is able
to distinguish B. pertussis from B. bronchiseptica and B. paraper-
tussis (22). Specificity evaluation was performed here using 3 B.
pertussis strains and 31 homologous species by both real-time tur-
bidimeter and visual color change methods. All B. pertussis strains
tested positive and all 31 non-pertussis respiratory tract pathogens,
including B. bronchiseptica and B. parapertussis, tested negative.
These results demonstrated that LAMP targeting BP485 had a high
specificity for the detection of B. pertussis and that using turbidity
or color change as readouts gave comparable results. The sensitiv-
ity of LAMP to detect BP485 was compared with traditional PCR
using 10-fold serial dilution of genomic DNA extracted from B.
pertussis. The detection limit of the LAMP assay used here was
1.3 pg/µl, 10-fold higher than conventional PCR, in agreement
with previous reports. Furthermore, LAMP can be completed in
one hour using a simple thermostat, whereas a PCR run takes
approximately 3 h and requires a relatively complicated thermal
cycler. LAMP is therefore a more rapid and simple technique
making it better suited to field use.
Two readouts were used for the LAMP assay to detect amplifica-
tion products, real-time turbidity and visual observation of color
change. Detection by color change was as sensitive and specific as
real-time turbidity measurements. As this color change is visible
to the naked eye, it would further simplify the assay. It is worth
noting that the use of a wax sealant over the reaction mixture
was essential to minimize cross contamination by aerosol, which
frequently resulted in false positives.
Application of the assay to samples taken from hospital admis-
sions of cough and pneumonia indicated that B. pertussis was
prevalent in the community with over 30% of samples testing pos-
itive. The cases included a 35-year-old female patient from rural
China who was admitted for treatment in the city hospital after
suffering with cough and pneumonia for 14 days. Her baby had
contracted whooping cough from her as a result of close contact.
This was an example of increasing numbers of “adult to child”
transmissions, which may be a major factor in the rising incidence
of pertussis.
In conclusion, the visual LAMP assay developed here for detect-
ing B. pertussis allows for positive samples to be identified by the
naked eye immediately after amplification is completed. The visual
method is as sensitive and specific as real-time turbidity mea-
surements and is more sensitive than PCR. It is a rapid, simple,
and low-cost method to diagnose B. pertussis, making it particu-
larly useful for point-of-care testing where time and resources are
limited.
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